Navigation Links
Oncothyreon's PX-866 is effective in preclinical model of pulmonary fibrosis
Date:5/18/2009

th in Orlando, Florida.

About PX-866

PX-866 is an inhibitor of the PI-3-kinase/PTEN/AKT pathway, an important survival signaling pathway that is activated in many types of human cancer. Aberrant activation and regulation of PI-3 kinase is implicated in a large proportion of human cancers including breast, glioma, colon, ovarian, prostate and melanoma, where it leads to increased proliferation and inhibition of apoptosis (programmed cell death). PX-866 has been shown to induce prolonged inhibition of tumor PI-3 kinase signaling following both oral and intravenous administration. The compound has been shown to have anti-tumor activity both as a single agent and in combination with other agents in a number of human tumor models. Oncothyreon initiated a Phase 1 trial of PX-866 in patients with advanced metastatic cancer in June 2008.

About Oncothyreon

Oncothyreon is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Oncothyreon's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients. For more information, visit www.oncothyreon.com.

Forward-Looking Statements

In order to provide Oncothyreon's investors with an understanding of its current intentions and future prospects, this release contains statements that are forward-looking, including statements related to future preclinical and clinical development plans for PX PX-866. These forward-looking statements represent Oncothyreon's intentions, plans, expectations and beliefs and are based on its management's experience and assessment of historical and future trends and the application of key assumptions relating to future events and circumstances.

Forward-looking statements involve
'/>"/>

SOURCE Oncothyreon Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. Data for Oncothyreons PX-12 and PX-866 presented at AACR Annual Meeting
2. Oncothyreon files investigational new drug application for PX-866 oncology compound
3. Oncothyreon initiates Phase 1 trial of PX-866 cancer compound
4. Phase III Trial Finds Pharmaxis Bronchitol Effective
5. New nanoparticle vaccine is more effective but less expensive
6. American and European Parkinsons Sufferers Find Chinese Stem Cell Treatment Effective, Proving Western Debates Moot
7. ProMed Alliance International Inc. Corporate Name and Trading Symbol Expected to Change Effective Tomorrow
8. InVitrias Animal Free Lacromin(TM) Provides a Cost-Effective Improvement Over Transferrin
9. MedImmune to Present RSV Surveillance and Cost-Effectiveness Data at American Academy of Pediatrics National Conference & Exhibition
10. Free White Paper Available for Clinical Laboratory Managers: Effectively Isolating Anaerobic Bacteria
11. DNA sensors found to be an effective artificial nose

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)... , COPENHAGEN, Nov. 19 Danish ...icon cellulosic ethanol plant in Kalundborg, Denma... of the world,s first and largest 2nd generation e...ellerase enzymes are used in the plant,s innovativ...a Division of Danisco, was the first to market wit...
(Date:11/19/2009)... , BLAUVELT, N.Y., Nov. 19 Dr... germ extract, responds to a press release issued ... Hungarian company for making false and self-servi...ioSciences. ,, Dr. Hidvegi stated from his off...laim that research on Avemar does not apply to Ave...
(Date:11/19/2009)... , NEW YORK, Nov. 19 /PRNewswire-FirstCall/ -...y that it has sent the following letter to its sha...n October 30, 2009, of China Biopharmaceuticals Ho...cal company based in the People,s Republic of Chin...rest in Suzhou Eyre Pharmaceutical Co. Ltd., CHBP,...
(Date:11/19/2009)... , MALVERN, Pa. and WALTHAM, Mass., Nov. ...R) and Decision Resources find that the leading dr...ia in Europe is broad-spectrum activity against gr...e variety of organisms that can cause nosocomial p... they look primarily for agents that provide appro...
Breaking Biology Technology:DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3
... Jan. 7 Amgen (Nasdaq: AMGN ) will present at t...nce at 9:00 a.m. Pacific Time on Monday, Jan. 12, ...Calif. Amgen Chairman and CEO Kevin Sharer will p...tation will be available over the Internet and can... , under Investors. , , (Logo: http://www.news...
... Cold season has settled in for the,winter months ...octor,appointments and missed days of school and w...our immune system. And Immunity Enhanced Beverage ...uced by Innovative Beverage Products, Immunity Enh...nt intended to strengthen the,body,s immune defens...
... Sangart, Inc., a privately held,biopharmaceutical...commercialization of oxygen-therapeutic agents, to...s the addition of four key leadership positions an... in the product manufacturing,area. This restructu...,Sangart,s business units on pursuing further clin...
Other Biology Technology:Innovative Beverage Products Launches New Product Designed to Enhance the Body's Immune Defense 2Sangart, Inc. Announces Key Executive Appointments and Company Restructuring 2Sangart, Inc. Announces Key Executive Appointments and Company Restructuring 3
(Date:11/23/2009)...coveries about the multiple health benefits of vit...nutrient, increased awareness of the huge numbers ...h and even led to an appreciation of it as "nature...lth of your immune system to prevention of heart d...n D is now seen as one of the most critical nutrie...
(Date:11/23/2009)...titute for Child Health Research has found evidenc...n in pregnancy affects child behaviour in differen...ne in the international journal Addiction . , L...rawn from a random sample of more than 2000 mother... the baby,s delivery, and were then followed up wh...
(Date:11/23/2009)... , Not just birds, but also a few species of...at Princeton University in the U.S. and at the Max...ermany studied the migratory behaviour of the larg...lionidae" with the help of mathematical models. Th...l as long distances of various kinds of bats evolv...
Breaking Biology News(10 mins):Multiple health concerns surface as winter, vitamin D deficiences arrive 2Multiple health concerns surface as winter, vitamin D deficiences arrive 3New study links alcohol in pregnancy to child behavior problems 2We're off then: The evolution of bat migration 2Life Saving Thermal Angel Blood Warmer Is Immediately Available For Use By U S Troops In Harms Way 51758 1Life Saving Thermal Angel Blood Warmer Is Immediately Available For Use By U S Troops In Harms Way 51758 2Life Saving Thermal Angel Blood Warmer Is Immediately Available For Use By U S Troops In Harms Way 51758 3Bayer HealthCare Announces Recipients of 2009 International Hemophilia Nursing Fellowship 51754 1Bayer HealthCare Announces Recipients of 2009 International Hemophilia Nursing Fellowship 51754 2Bayer HealthCare Announces Recipients of 2009 International Hemophilia Nursing Fellowship 51754 3Bayer HealthCare Announces Recipients of 2009 International Hemophilia Nursing Fellowship 51754 4Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 1Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 2Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 3Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 4Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 5Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 6Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 7Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 8Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 9Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 10Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 11Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 12Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 13Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 14Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 15Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 16Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 17Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 18Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 19Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 20Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 21
...t colorful birds in the world may have a less-than...the parrot family, have seen their numbers decline...oday. , Dr. Don Brightsmith, a bird specialist at...nter, part of the College of Veterinary Medicine &... sure macaws will not just be photos in a book one...
...logists who performed the first-ever computed tomo... believe they have solved the mystery of how the a...their study were presented today at the annual mee...(RSNA). , Ashraf Selim, M.D., radiologist at Kasr ...t, was part of an international team of scientists...
...al group of researchers today unveiled a detailed ...stocompatibility complex (MHC), the most important...ponse to infection, autoimmune disease and organ t... the analysis of genetic variability for this fund...dation for future efforts aimed at uncovering the ...
Other Biology News:Disappearing nest egg: Researcher studying declining numbers of macaws 2Radiologists attempt to solve mystery of Tut's demise 2International team analyzes human genetic variation in key immune region 2International team analyzes human genetic variation in key immune region 3
...ve been developed for affinity capture of proteins... chemical surfaces allow differential capture of p...erties. Each chip has eight different spots, allow...are color-coded with a unique hydrophobic coating....
SmartSpec Printer Paper, 5 pack from Bio-Rad
...ve been developed for affinity capture of proteins... chemical surfaces allow differential capture of p...erties. Each chip has eight different spots, allow...are color-coded with a unique hydrophobic coating....
...abeled Substrates (red fluorescence; Ex=590 nm, Em... activation • No lysing, fixing, or permeabil...permeable, fluorescently labeled inhibitors of ser...e activity in whole living cells. Select from seve...
Biology Products: